NXgenPort


NXgenPort is a biomedical technology company focused on developing innovative remote patient monitoring solutions for cancer patients requiring implantable chemo-port catheters. Combining proven efficacy with microchip and sensor technology, NXgenPort aims to enhance early detection of complications, improve patient outcomes, and enable remote management of physiological functions during treatment.

Industries

health-care
medical-device

Nr. of Employees

small (1-50)

NXgenPort

Saint Paul, Minnesota, United States, North America


Products

Implantable sensor-enabled port-catheter (prototype, not market authorized)

An implantable port-catheter incorporating miniaturized microelectronic/optical sensors designed to measure physiologic parameters in vivo and transmit data to a remote monitoring platform. Product is in development and has not received market authorization.


Services

Clinical collaboration for prototype development and testing

Partnerships with healthcare institutions to refine product specifications, plan and execute prototype testing, and design pre-clinical/clinical validation pathways.

Remote monitoring data platform and analytics

Collection, analytics and reporting of device telemetry to provide clinicians with real-time trends, alerts, and actionable reports to support virtual patient management.

Expertise Areas

  • Remote patient monitoring
  • Implantable medical device design
  • Clinical validation and trial support
  • Digital health data analytics and machine learning
  • Show More (4)

Key Technologies

  • Implantable port-catheter devices
  • Microelectronic sensors
  • Optical sensors
  • In‑vivo physiologic monitoring
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.